Medtronic’s MiniMed Paradigm REAL-Time Revel System Receives FDA Approval

Medtronic has received FDA approval for its integrated diabetes management system called MiniMed Paradigm REAL-Time Revel System. The system combines insulin pump therapy, continuous glucose monitoring and diabetes therapy management software. It features predictive alerts which signal trends in blood glucose levels notifying patients to take preventive measures. For maximal comfort it can be combined with the Medtronic wireless continuous glucose monitoring system and measurements can be uploaded to the online Carelink personal management software. The system is made available immediately in five different colors.
Press release: Medtronic Receives FDA Approval for Industry’s Most Advanced Integrated System for Diabetes Management …
Product page: MiniMed Paradigm&reg Revel™ Insulin Pump …
NOTE: We would like to welcome Dr. Wouter Stomp to Medgadget editorial board. He is an MD from the Netherlands, currently working on PhD in radiology. This is his first post.